[Kallikrein in a double-blind study  in idiopathic oligozoospermia].
In a double blind study the effectivity of kallikrein (Padutin 100) was investigated in 90 men with idiopathic oligozoospermia. After oral application of kallikrein (600 Kallikrein units per day) over a period of seven weeks a statistically significant increase of the sperm number and sperm motility was observed compared to the placebo group. The conception rate was 38% in the kallikrein group and 16% in the placebo group.
D000328:Adult; D002452:Cell Count; D004311:Double-Blind Method; D006801:Humans; D007610:Kallikreins / Q000627:therapeutic use*; D008297:Male; D009845:Oligospermia / Q000188:drug therapy*; D010919:Placebos; D012661:Semen / Q000032:analysis; D013094:Spermatozoa / Q000032:analysis
D010919:Placebos; D007610:Kallikreins
Kallikrein im Doppelblindversuch bei idiopathischer Oligozoospermie.